drug protocol number

CT20/001/R

drug sponsor

KAIMRC

drug study

• Ceftriaxone • Piperacillin Tazobactam • Azithromycin • Interferon β1-a • Hydrocortisone sodium suc.• Hydroxychloroquine • OSELTAMIVIR • Lopinavir-Ritonavir

drug trial site

King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase